New Launch | Total PSA Rapid Test Kit (Colloidal Gold): A Reliable Choice for Men’s Prostate Health
Prostate health is frequently overlooked by men in daily health management, making potential underlying risks easy to ignore. As a globally recognized and efficient screening approach, PSA testing enables intuitive health assessment. To simplify screening procedures and lower detection barriers, we are proud to launch our Total PSA Rapid Test Kit. The total psa rapid test kit can work as the prostate cancer screening test. Featuring user-friendly operation and dependable stability, this kit delivers accessible routine screening, helping men achieve early awareness and greater peace of mind.
Adopting mature colloidal gold immunochromatography technology, our semi-quantitative PSA test kit is perfectly optimized for preliminary daily screening. In strict accordance with the 2026 EAU (European Association of Urology) Guidelines—which clearly states In a screening situation, the most frequently applied threshold for PSA is ≥ 3.0ng/mL—we set 3.0 ng/mL as the official screening cutoff to align with international medical standards. Unlike high-precision laboratory quantitative devices, this total PSA rapid test kit supports visual interpretation without professional equipment. It effectively distinguishes whether the sample falls within the 3~10 ng/mL gray interval or exceeds the critical threshold. Results can be obtained within 10~15 minutes, catering to both primary medical institutions and convenient at-home self-testing.
Supported by rigorous quality control, the kit boasts strong anti-interference performance and minimizes detection errors to ensure consistent and trustworthy results. Wizbiotech total psa rapid test kit features flexible storage conditions with a temperature range of 2~30°C, requiring no cold-chain transportation to reduce logistics and warehousing costs. Benefiting from a 24-month shelf life, the product is ideal for bulk stocking and long-term storage, delivering outstanding cost performance for medical procurement, retail sales, and household reserves.
Per the official EAU 2026 guidelines, targeted periodic screening is recommended for defined high-risk populations. For average-risk men, routine PSA screening is suggested from the age of 50. Individuals with a family history of prostate cancer and men of African ethnicity are recommended to start screening at 45 years old, while BRCA2 mutation carriers should commence monitoring at 40 years old. Designed for versatile application, this semi-quantitative psa rapid test kit enables simple and regular prostate monitoring for all high-risk groups.
We adhere to strict manufacturing and repeated quality verification to maintain premium product standards. This new product (men health test kit) launch aims to break the barriers of professional medical screening and deliver reliable, cost-effective rapid testing solutions for male prostate care. Now officially available for sale, our kit supports bulk inquiry and procurement, building a simple yet solid health defense for medical institutions and individual families.
